© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Oct 02, 2015, the consensus forecast amongst 24 polled investment analysts covering Procter & Gamble Co advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Apr 27, 2015. The previous consensus forecast advised that Procter & Gamble Co would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 16 analysts offering 12 month price targets for Procter & Gamble Co have a median target of 80.00, with a high estimate of 96.00 and a low estimate of 70.00. The median estimate represents a 8.99% increase from the last price of 73.40. View Full Financials
In 2015, Procter & Gamble Co reported a dividend of 2.59 USD, which represents a 5.71% increase over last year. The 10 analysts covering the company expect dividends of 2.69 USD for the upcoming fiscal year, an increase of 3.75%. View Full Financials
|Div growth (TTM)||+5.71 %|
On Jul 30, 2015, Procter & Gamble Co reported 4th quarter 2015 earnings of 1.00 per share. This result exceeded the 0.95 consensus of the 20 analysts covering the company and exceeded last year's 4th quarter results by 5.26%.
The next earnings announcement is expected on Oct 22, 2015. View Full Interim Financials
|Average growth rate||+1.80 %|
Procter & Gamble Co reported annual 2015 earnings of 4.02 per share on Jul 30, 2015. View Full Annual Financials
|Average growth rate||+0.53 %|
The Procter & Gamble Company had 4th quarter 2015 revenues of 17.79bn. This missed the 17.98bn consensus estimate of the 15 analysts following the company. This was 11.74 % below the prior year's 4th quarter results. View Full Interim Financials
|Average growth rate||-2.96 %|
The Procter & Gamble Company had revenues for the full year 2015 of 76.28bn. This was 8.17 % below the prior year's results. View Full Annual Financials
|Average growth rate||-1.88 %|